'Inauguration of Manufacturing Facility F-10 and commencement of commercial production of the Company'
As filed · Anuh Pharma Limited has informed the Exchange regarding 'Inauguration of Manufacturing Facility F-10/1 and commencement of commercial production of the Company'.
BusinessMinormateriality 59 out of 100
What happened
FactInauguration of Manufacturing Facility F-10/1 and commencement of commercial production of the Company'. The new plant is expected to become fully operational within December, 2026, and upon.
Why it matters
CapitSignal interpretationNew capacity spends capital now for volume later; the commissioning date is the commitment that can be checked against subsequent filings.
Watch next
Fact- Stated commissioning date
- Capital outlay and how it is funded
- Expected asset turns at full utilisation
- The company anticipates a steady growth rate of 15‐16% per annum. (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- CAPACITY_EXPANSION base 54; +5 quantified amount; matched on body
- Matched on:
- body text (weaker evidence than a subject match)
- Confidence in the event type:
- 50%